Page 5 - Iontech En News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech en. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech En Today - Breaking & Trending Today

BioNTech licenses bispecific antibody for cancer in $1 billion deal

The German mRNA giant BioNTech has sealed a pact worth up to $1 billion with Biotheus to develop the Chinese biotech company’s bispecific antibody cancer drug PM8002 in all territories except for Greater China. ....

Xiaolin Liu , Antibody Drug Conjugates , Bio Developments , Bispecific Antibodies , Monoclonal Antibodies , Cell Culture ,

The company run by Ursula von der Leyen's husband produces anti-covid vaccines with European money

European Commission President Ursula von der Leyen said last week at the Global Gateway Forum in Brussels that she funded a 1.2 billion euro project through which BioNTech and Univercells built modular factories in Rwanda for the production of the vaccine with messenger RNA. ....

United States , New York , Bruxelles Capitale , South Africa , Albert Bourla , Laura Codru , Melinda Gates Foundation , European Public Prosecutor Office , Team Europe Initiative , European Union , Global Gateway Forum , European Investment Bank , Team Europe , New York Times , African Union , European Commission , Orgenesis Inc , European Commission President Ursula , Community Executive , Global Gateway , Latin America , Melinda Gates , President Ursula , Vaccine Manufacturing , Africa Among , European Public Prosecutor ,

Global Gateway - the business of the von der Leyen family

Global Gateway, the European Union's euro300 billion global investment program, appears to be one in which the von der Leyens take the lion's share. ....

South Africa , United States , New York , Laura Codru , Albert Bourla , New York Times , Global Gateway Forum , European Public Prosecutor Office , European Commission , Orgenesis Inc , European Union , Team Europe , Global Gateway , Community Executive , Latin America , European Public Prosecutor , Ursula Von Der Leyen , Global Gateway ,

Combined COVID-flu vaccine from Pfizer, BioNTech moving to late-stage testing

Pfizer and BioNTech announced Thursday it would soon begin a Phase 3 trial for its combined flu and COVID-19 mRNA vaccine following “positive” results from its Phase 1/2 study. Phase 1 and 2 trials are meant to evaluate whether a new drug or treatment is both safe and effective. An official for Pfizer said Thursday… ....

Xavier Becerra , Annaliesa Anderson , Drug Administration , Human Services , Fast Track Designation , Human Services Secretary Xavier Becerra , Mrna Vaccine , Vaccine Research And Development , Vaccine Uptake , Phase 3 Trial , Respiratory Diseases , Annaliesa Anderson ,

BioNTech Climbs On Positive Data From BNT211 Trial

BioNTech SE (BNTX) shares are adding more than 4 percent on Tuesday morning trade after the company reported positive data for its first-in-human Phase 1/2 trial of Claudin-6, CAR-T cell therapy candidate BNT211 in patients with CLDN6-positive refractory/relapsed solid tumors. ....

Stock Alert ,